Related to Response Genetics Offers New Test for Lung Cancer Biomarker

• Champions Biotechnology Gains Rights to Ramot’s Preclinical Anticancer Agent
  
• FDA Approves AdvanDx’ Faster PNA FISH Protocol for Identifying Enterococcal Bloodstream Pathogens
  
• Biosearch Grants Micronics Rights to Its Nucleic Acid Assay Chemistries
  
• Micromet Obtains $11.84M Up Front in Cancer R&D Deal with Sanofi-Aventis
  
• FDA Grants Emergency Use Authorization to Gen-Probe's PCR Test for the H1N1 Flu
  
• Astex Signs CRADA with NCI to Investigate Its Small Molecule Therapeutic
  
• Calbiotech Wins Phase I SBIR Contract to Develop Blood-Based Dengue Fever Diagnostic
  
• Boehringer Ingelheim Pledges $22.5M to Fund Another Four Years of Partnership with Evotec
  
• Chinese Authorities Clear China Medical’s Leukemia Diagnostic Kit
  
• Duke University and Jubilant Plan on Initiating a Drug and Biomarker Collaboration
  
• Gene Pinpointed that Could Negate Cancer Cells’ Ability to Repair Themselves
  
• Targeting a Tumor’s Microenvironment Could Be Used to Treat Cancer
  
• Enzo to Market GeneNews’ Colorectal Cancer Blood Test in NY and NJ
  
• Amgen to Apply ImmunoGen TAP Technology to Another Cancer Target
  
• Clovis Negotiates Potentially $380M Deal to Develop Clavis Pharma’s Lipid-Conjugated Gemcitabine
  
• Oncodesign to Provide Sanofi-Aventis with Exclusive Cancer Models
  
• Proven Diagnostics to Provide Cardiovascular Tests from Berkeley HeartLab
  
• Biofortuna Chooses Lab901’s ScreenTape System for Multiplex PCR Diagnostic Kits
  
• Novartis Signs Four-Year Deal with Horizon for Custom-Generated X-Man Cancer Models
  
• EraGen and Illumina Enter Cross-Licensing Deal for Molecular Diagnostics